Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/18/03 → 5/31/05 |
Funding
- Boehringer-Ingelheim: $32,786.00
A Randomized Double-Blind Placebo-Controlled Study to Investigate the Efficacy and Safety of 24 Weeks of Oral Treatment with BIIL 284 BS in Adult(75mg,150mg) and Pediatric(75mg) Cystic Fibrosis Patients
- Anstead, Michael (PI)